What Is TRT? Testosterone Replacement Therapy Explained

Your doctor ran your testosterone. The number came back at 310, and they said everything looks fine. So why do you still feel like garbage?

That's the question that sends most men down the TRT rabbit hole. Fatigue that coffee can't touch. Gym sessions that stopped producing results. A libido that went quiet sometime in your late thirties. Regular blood work that says "normal" while your body tells you something different.

Testosterone replacement therapy (TRT) is the medical answer when your testosterone has genuinely fallen below the level your body needs to function well. It's FDA-approved, physician-prescribed, and backed by decades of clinical research. It's also one of the most misunderstood treatments in medicine, surrounded by equal parts hype and fear.

This guide cuts through both. What TRT actually is, who legitimately qualifies, what the research shows, and what to expect if you start a protocol.

---

What Is TRT?

Testosterone replacement therapy (TRT) is a physician-prescribed treatment that restores testosterone to normal physiologic levels in men and women diagnosed with hypogonadism. It's FDA-approved for this indication, available in several delivery formats, and managed through ongoing labs and clinical monitoring.

The "replacement" part matters. TRT is not about pushing testosterone above normal for performance enhancement. The goal is to restore what your body is no longer producing at adequate levels — getting you back to where you should be, not somewhere beyond it (Bhasin et al., 2018).

Testosterone is a steroid hormone produced primarily in the testes in men and in smaller amounts in the ovaries and adrenal glands in women. It drives muscle protein synthesis, bone density, red blood cell production, libido, energy regulation, and mood stability. When production drops significantly, so does quality of life in ways that are hard to ignore but easy to dismiss as "just aging."

TRT replaces what's missing.

---

Who Qualifies for TRT?

Qualifying for TRT requires two things: clinical symptoms and confirmed low testosterone levels on lab work. Neither one alone is enough.

The clinical threshold for low testosterone is a total T below 264-300 ng/dL on two separate morning draws (Bhasin et al., 2018). Morning is non-negotiable: testosterone follows a circadian rhythm, with levels peaking between 7 and 10 AM. An afternoon draw can look 20-30% lower than a morning draw in the same person. Two separate measurements rule out day-to-day variability.

Symptoms matter just as much as the number. A man at 310 ng/dL with severe fatigue, muscle loss, brain fog, and near-zero libido may be a better candidate than someone at 290 ng/dL who feels fine. Clinical judgment requires looking at both.

Common symptoms in men:

• Persistent fatigue not explained by sleep or workload
• Loss of muscle mass despite consistent training
• Decreased libido
• Erectile dysfunction or poor morning erections
• Brain fog and difficulty concentrating
• Depressed mood or increased irritability
• Increased body fat, particularly in the abdomen

Women also experience symptoms of low testosterone, though the thresholds differ. Fatigue, reduced libido, difficulty building or maintaining muscle, and mood instability are the primary complaints. The lab reference ranges for women are substantially lower than for men (typical female range: 15-70 ng/dL).

For a deeper look at the full symptom picture, see our guide to Low Testosterone Symptoms.

Primary vs. Secondary Hypogonadism

This distinction determines what TRT can and can't fix, and whether there are alternatives worth considering first.

Primary hypogonadism is a problem with the testes themselves. The testes aren't producing enough testosterone despite adequate signaling from the brain. Causes include injury, infection, genetic conditions (Klinefelter syndrome), chemotherapy, and age-related testicular decline. Labs show low testosterone with elevated LH and FSH; the pituitary is sending strong signals, but the testes aren't responding.

Secondary hypogonadism is a brain-signaling problem. The pituitary isn't releasing enough LH and FSH to stimulate the testes, so testosterone drops as a downstream consequence. Common causes include obesity, sleep apnea, pituitary tumors (even small, benign ones), anabolic steroid use history, opioid use, and chronic stress. Labs show low testosterone with low or inappropriately normal LH and FSH.

Why does the distinction matter? In secondary hypogonadism, medications like clomiphene citrate or enclomiphene can restore testosterone by stimulating the pituitary, without suppressing the body's own production or affecting fertility the way exogenous testosterone does. For men who want to preserve fertility, that's often the first path worth discussing with a provider. See our Enclomiphene Guide for a full breakdown.

---

The Lab Panel You Need Before Starting

Starting TRT without a complete baseline panel is a mistake you'll pay for later. These labs aren't optional; they're how your provider confirms the diagnosis, rules out contraindications, and sets the benchmark for monitoring.

Required labs before TRT:

Lab	Why It Matters
Total testosterone (AM draw)	The headline number — must be below threshold on two draws
Free testosterone	Active, usable form — low free T with normal total T still matters
SHBG (sex hormone-binding globulin)	High SHBG reduces free T; low SHBG means more free T than total suggests
Estradiol (E2)	Testosterone converts to estrogen; elevated E2 causes side effects
LH and FSH	Distinguishes primary from secondary hypogonadism
PSA (men over 40)	Baseline before starting; prostate safety monitoring
Hematocrit/hemoglobin	TRT raises red blood cell production — polycythemia is a real risk
Metabolic panel	Liver and kidney function baseline

Your provider will also want a physical exam, medical history, and discussion of goals. The labs tell part of the story. The full picture requires context.

SHBG deserves more attention than most articles give it. If your SHBG is high (which happens with age, liver conditions, hyperthyroidism, and certain medications) a large portion of your testosterone gets bound up and rendered inactive (Lazarou & Morgentaler, 2005). You can have a "normal" total T of 450 ng/dL with high SHBG and functionally behave like someone at 250. Free testosterone is what your cells actually use.

---

TRT Delivery Methods: The Main Options

Testosterone is FDA-approved in several delivery formats. Each has real trade-offs around convenience, cost, stability, and side effects. The right method depends on your lifestyle, preference, and how your body responds.

Intramuscular or subcutaneous injections are the most common and cost-effective option. Testosterone cypionate and testosterone enanthate are the standard injectable forms, typically dosed weekly or twice weekly to keep levels stable. Injections give the most precise dosing control and are the format most commonly used in clinical TRT protocols. Testosterone cypionate is the most widely used in the US. For a complete breakdown of this form, see our Testosterone Cypionate guide.

Transdermal gels and creams are applied daily to the skin (typically the shoulders, upper arms, or thighs). They're convenient and needle-free, but absorption varies between individuals. Skin-to-skin transfer is a real concern if you have children or a partner; wash hands thoroughly and keep treated areas covered.

Subcutaneous pellets are small, rice-sized pellets implanted under the skin every 3-6 months, releasing testosterone gradually over time. Convenience is the main advantage; dose adjustment requires another procedure.

Buccal tablets (placed between the gum and cheek) and nasal gels are less commonly used but are available options.

For a side-by-side comparison of all delivery methods with dosing ranges, absorption rates, and cost, see our guide to TRT Delivery Methods.

---

What TRT Actually Does to Your Body

TRT works through the same mechanisms as endogenous testosterone; it binds to androgen receptors throughout the body and produces downstream effects on muscle, bone, fat, blood cells, libido, and mood.

The research on what TRT reliably improves is more specific than the marketing suggests.

What the evidence consistently supports: In a systematic review of randomized controlled trials and observational studies analyzing TRT outcomes in men with confirmed hypogonadism (total T below 12 nM, roughly 346 ng/dL), testosterone replacement consistently improved erectile function, libido, and other sexual activity measures (Corona et al., 2020). These are the most well-established benefits across the literature.

Body composition: TRT increases lean muscle mass and reduces fat mass in men with hypogonadism, but the magnitude depends heavily on baseline testosterone level, dose, duration, and whether the patient is also strength training (Lazarou & Morgentaler, 2005). You don't get muscle by injecting testosterone and sitting still.

Bone density: Low testosterone is associated with increased fracture risk and osteoporosis in men. TRT has been shown to improve bone mineral density, particularly in the lumbar spine and hip (Zitzmann, 2024).

Anemia correction: A randomized controlled trial of 5,204 men with hypogonadism found that testosterone-treated men corrected existing anemia at significantly higher rates than placebo-treated men, and developed new-onset anemia at lower rates (Pencina et al., 2023). This is a frequently overlooked benefit.

Mood and cognition: Effects are real but variable. Men who feel depressed or foggy because of low testosterone often see meaningful improvement (Zitzmann, 2024). But TRT doesn't treat clinical depression that exists independently of low T. The two can overlap and the distinction matters.

What TRT doesn't reliably produce (based on the trial data, not the forums): dramatic physical transformation in 8 weeks, resolution of symptoms unrelated to hormone levels, or effects comparable to supraphysiologic doses used in bodybuilding contexts.

---

The TRAVERSE Trial: What We Know About Cardiovascular Safety

For years, TRT's relationship with cardiovascular risk was genuinely uncertain. A 2010 trial was halted early due to apparent cardiovascular harm. A 2013 observational study suggested increased risk. The uncertainty created real hesitation among prescribers.

The TRAVERSE trial resolved much of this (Lincoff et al., 2023). Published in the New England Journal of Medicine in 2023, TRAVERSE was a randomized, placebo-controlled trial of 5,204 men aged 45-80 with hypogonadism and either existing cardiovascular disease or elevated cardiovascular risk. Participants received testosterone gel or placebo for a median of 22 months.

The primary cardiovascular outcome (a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) showed non-inferiority for testosterone. In plain terms: TRT did not increase the rate of major cardiovascular events compared to placebo in this high-risk population.

TRAVERSE also showed that testosterone increased the rate of atrial fibrillation and pulmonary embolism compared to placebo, and these findings matter for individual risk assessment. It confirmed that prostate cancer occurred at similar rates in both groups.

The takeaway for most clinicians: TRT in properly diagnosed hypogonadal men does not carry the cardiovascular catastrophe risk that earlier signals suggested, but it's not without any risk, and individual risk profiles, particularly around clotting and arrhythmia, need evaluation before starting.

---

Realistic Timelines: When Do You Feel It?

The TRT timeline that circulates on forums doesn't always match what the research and clinical experience actually show. Here's a more accurate picture.

Weeks 1-3: Some men notice improved sleep quality and libido fairly quickly. Some notice nothing. Placebo effects are real in this window and make it hard to separate signal from noise.

Weeks 3-6: Energy and mood often begin to improve. This is when many men first feel a meaningful difference.

Months 2-3: Body composition changes become measurable. You'll likely see some increase in strength and training capacity. Fat loss (if it's happening) starts showing at this point, especially with consistent training.

Months 3-6: Full effects on libido, erections, mood, energy, and body composition are typically established by month 6. This is why most providers don't make major protocol changes before the 3-month mark.

Beyond 6 months: Bone density improvements accumulate over 1-2 years. Erythropoietic effects (red blood cell increases) develop gradually and require ongoing hematocrit monitoring.

Symptom resolution is not all-or-nothing. Some men see dramatic improvement. Others see partial improvement that requires protocol adjustment. A few see no meaningful change despite optimized levels. TRT is not a guarantee. It's a medical intervention with individual variability.

---

Fertility: The Conversation Most Clinics Skip

Exogenous testosterone suppresses the body's natural production of LH and FSH (Bhasin et al., 2018). Without LH, the testes stop producing testosterone internally. Without FSH, sperm production (spermatogenesis) drops dramatically, often to zero.

This is the fertility conversation that many TRT clinics skip, and it catches younger men completely off guard.

If you have any chance of wanting biological children, this needs to be discussed with your provider before starting TRT (Lazarou & Morgentaler, 2005). The options:

HCG (human chorionic gonadotropin) mimics LH and can maintain intratesticular testosterone levels and some degree of spermatogenesis during TRT. Many protocols combine TRT with HCG specifically for this reason, particularly in younger men.

Enclomiphene is a selective estrogen receptor modulator that stimulates the pituitary to release LH and FSH, raising testosterone through your own production pathway. For men with secondary hypogonadism who want to preserve fertility, enclomiphene is often the first option to try before committing to exogenous testosterone. See our Enclomiphene Guide for how this compares to TRT.

Cessation for fertility: Men who stop TRT typically recover sperm production over months to years, but recovery is not guaranteed and timeline varies significantly. Starting TRT at 28 with no fertility discussion is a decision that can have consequences you didn't fully consider.

The HEXIS approach: fertility goals are part of the intake conversation, not an afterthought.

---

Who Should NOT Start TRT

TRT is contraindicated in certain situations (Bhasin et al., 2018). These aren't bureaucratic fine print; they're real clinical risks that require evaluation before prescribing.

Active prostate cancer. Testosterone is contraindicated in men with active prostate cancer. This does not mean a history of treated prostate cancer is always a disqualifier; clinical context matters. But active disease is a hard stop (Bhasin et al., 2018).

Breast cancer. Both in men (rare) and in women receiving testosterone therapy, active breast cancer is a contraindication.

Uncontrolled polycythemia. TRT increases red blood cell production. If your hematocrit is already elevated and uncontrolled, adding TRT worsens the risk of blood clotting events. This requires evaluation and possible management before starting.

Untreated or severe sleep apnea. OSA worsens with TRT in some men. Untreated severe sleep apnea should be addressed first. Not because TRT is impossible alongside it, but because treating sleep apnea often improves hormonal function on its own, and combining untreated severe OSA with TRT carries real risk.

Desire for biological children (without a fertility preservation plan). Not a hard contraindication, but requires a different conversation about HCG co-administration or alternative protocols before TRT is initiated.

Elevated PSA without evaluation. An elevated PSA needs to be investigated before starting TRT, not ignored.

---

WADA Status and the Doping Distinction

Testosterone is prohibited by the World Anti-Doping Agency (WADA) under the S1 Anabolic Agents category (WADA, 2024). This matters if you compete in any sport governed by WADA or USADA rules, including professional sports, certain masters-level competitions, and many amateur athletic organizations.

If you compete, talk to your sports organization about the Therapeutic Use Exemption (TUE) process before starting TRT. A TUE allows medically necessary testosterone use in athletes with documented hypogonadism, but it requires documentation, application, and approval. It's not automatic.

This is also where the important distinction between therapeutic TRT and performance-enhancing testosterone use lives. TRT replaces what's missing. It does not dose testosterone to supraphysiologic levels for competitive advantage. A protocol that keeps you in the normal physiologic range (generally 400-900 ng/dL for men) is medically distinct from doping, even though both involve exogenous testosterone.

---

Cost, Coverage, and How to Access TRT

TRT is not covered by most insurance plans in the same straightforward way that other medications are. The coverage picture is complicated, and it's worth understanding before you start.

Without insurance: Generic testosterone cypionate (the most commonly prescribed injectable) costs around $20-50/month at major pharmacies. Gels and branded formulations cost significantly more: $200-800/month without coverage. Lab work adds to the cost, typically $100-300 per panel depending on the tests ordered and the lab.

With insurance: Coverage for testosterone itself is more common than for labs and monitoring visits, particularly when the diagnosis is clearly documented. However, many insurance plans require step therapy (trying cheaper options first), prior authorization, or only cover certain formulations. Telehealth TRT providers often bill as cash-pay, which means no insurance involvement, and prices reflect that.

What you're actually paying for at a telehealth clinic: The honest breakdown typically includes an initial consultation and labs, a protocol, a prescription, and ongoing monitoring visits. Legitimate TRT clinics include monitoring in the model — the ones that email you a prescription without reviewing your labs are skipping the part that keeps you safe. That monitoring is where the safety lives.

At HEXIS: We start every TRT evaluation with labs, not guesswork. Your first visit includes a complete hormone panel, and your protocol is built from your actual numbers. We don't do cookie-cutter dosing. Schedule a consultation to see what your labs say and what TRT would actually look like for your situation.

---

Frequently Asked Questions About TRT

Is TRT for life once you start?

Not necessarily, but for most men with true hypogonadism, it becomes a long-term therapy. Once exogenous testosterone suppresses your own production, stopping TRT means your natural levels return — which, if you had hypogonadism to begin with, means they return to low. Some men cycle off with HCG or clomiphene to attempt to restore natural production. Recovery varies widely. If you're starting TRT because of primary hypogonadism (the testes themselves are the problem), long-term therapy is generally expected.

Will TRT make me aggressive or change my personality?

The short answer: probably not, and the opposite is more common in men with clinical hypogonadism. Mood instability, irritability, and depressed affect are symptoms of low testosterone. Restoring levels to normal frequently improves mood rather than making it worse. The "roid rage" association comes from supraphysiologic doses in bodybuilding contexts, not physiologic replacement therapy. That said, individual responses vary, and any meaningful behavioral change after starting TRT should be discussed with your provider.

Can TRT affect erectile function?

Yes, but not always in a linear way. TRT improves erectile function in many men with hypogonadism, particularly when low libido and poor morning erections are part of the symptom picture. However, TRT is not primarily an ED treatment. ED has multiple causes, and low testosterone is just one of them. A man with ED caused by vascular disease won't have that fixed by TRT. If ED is a primary concern, a broader evaluation is worth having. Our guide to how long ED medications last covers the pharmacologic options.

What happens to my hematocrit on TRT?

Testosterone stimulates erythropoiesis (red blood cell production). Most men on TRT see a modest hematocrit increase. This is generally not a problem. But when hematocrit rises above 54%, the blood becomes viscous enough to increase clotting risk. This is why hematocrit monitoring is standard on TRT, typically checked at 3 months, 6 months, and then annually. If it rises too high, dose adjustment, donation, or therapeutic phlebotomy are options. Don't skip your follow-up labs.

What misconceptions do people have about TRT?

Several common ones: that TRT is only for older men (men in their 30s and even late 20s can have clinical hypogonadism), that it causes prostate cancer (the TRAVERSE trial found no significant difference in prostate cancer rates), that it's the same as steroid use (physiologic replacement is categorically different from performance doses), and that symptoms alone are enough to start (labs must confirm low T before treatment begins). The biggest misconception may be that TRT is simple. It requires proper diagnosis, ongoing monitoring, and a provider who understands the full picture.

---

The Bottom Line

TRT is FDA-approved, clinically meaningful, and genuinely helpful for men and women who actually have low testosterone. It's not a shortcut, not a replacement for training and nutrition, and not something to start without proper labs confirming the diagnosis.

If you've been told your testosterone is "fine" but you don't feel fine, ask what the actual number was. Context matters. Lab timing matters. The full panel matters.

A number without context is just a number. What matters is how that number fits into your full hormonal picture: SHBG, free T, estradiol, LH, FSH, and your symptoms together.

Your protocol starts with labs, not guesswork. If you want to know where your levels stand and what, if anything, would actually change by optimizing them, schedule a consultation with HEXIS Health.

---